Guangxi Liuyao Group 柳药集团
9 significant filings since 29 May 2026: 4 on guarantee or financial assistance, 3 on buyback and 1 on pledge released, and 1 other kind. The latest, on 10 Sep 2026: 广西柳药集团股份有限公司关于为下属控股子公司提供担保的进展公告. 1 unverified report logged, the latest on 21 Aug 2026.
自 29 May 2026 起有 9 份重大公告：guarantee or financial assistance 4 份、buyback 3 份、pledge released 1 份，另有 1 类。最新一份（10 Sep 2026）：广西柳药集团股份有限公司关于为下属控股子公司提供担保的进展公告。记录了 1 条未经核实的报道，最新一条见于 21 Aug 2026。
The tick on each bar marks the whole market, where 99.3% of rated reports in the same twelve months said Buy or Outperform. 刻度线为全市场水平：同期 99.3% 的评级为买入或跑赢。 Every rated report on this company said Buy or Outperform.
| Date 日期 | Broker 券商 | Analyst 分析师 | From 原评级 | To 新评级 | |
|---|---|---|---|---|---|
| 5 Nov 2018 | 民生证券 | 肖汉山,袁中平 | Outperform 增持 | ▲ | Buy 买入 |
| 26 Aug 2018 | 民生证券 | 肖汉山,袁中平 | Buy 买入 | ▼ | Outperform 增持 |
| 22 Aug 2017 | 东吴证券 | 全铭,焦德智 | Buy 买入 | ▼ | Outperform 增持 |
| 22 Mar 2017 | 广证恒生证券研究所 | 唐爱金,陈家华,冯俊曦 | Outperform 增持 | ▲ | Buy 买入 |
Each broker's rating is compared with its previous report. 每家券商的评级与其上一份研报比较。
| Broker 券商 | Analyst 分析师 | Latest Rating 最新评级 | Date 日期 | Reports 研报 | Target 目标价 |
|---|---|---|---|---|---|
| 西南证券 | 杜向阳 | Unrated | 14 May 2026 | 1 | — |
| 中邮证券 | 盛丽华,龙永茂 | Buy 买入 | 12 Dec 2025 | 2 | — |
Each row is a broker's latest report in the last twelve months. A price target is given in 0 of 3 reports. 每行为该券商近十二个月的最新研报；3 份中 0 份给出目标价。
Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数，最近一个季度尚未结束。